Cargando…
RD-MolPack technology for the constitutive production of self-inactivating lentiviral vectors pseudotyped with the nontoxic RD114-TR envelope
To date, gene therapy with transiently derived lentivectors has been very successful to cure rare infant genetic diseases. However, transient manufacturing is unfeasible to treat adult malignancies because large vector lots are required. By contrast, stable manufacturing is the best option for high-...
Autores principales: | Marin, Virna, Stornaiuolo, Anna, Piovan, Claudia, Corna, Stefano, Bossi, Sergio, Pema, Monika, Giuliani, Erica, Scavullo, Cinzia, Zucchelli, Eleonora, Bordignon, Claudio, Rizzardi, Gian Paolo, Bovolenta, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863723/ https://www.ncbi.nlm.nih.gov/pubmed/27222840 http://dx.doi.org/10.1038/mtm.2016.33 |
Ejemplares similares
-
Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes
por: Piovan, Claudia, et al.
Publicado: (2017) -
Codon Optimization Leads to Functional Impairment of RD114-TR Envelope Glycoprotein
por: Zucchelli, Eleonora, et al.
Publicado: (2017) -
Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes
por: Tomás, Hélio A., et al.
Publicado: (2019) -
Characterization of a 3(rd) Generation Lentiviral Vector Pseudotyped With Nipah Virus Envelope Proteins For Endothelial Cell Transduction
por: Witting, Scott R., et al.
Publicado: (2013) -
3rd MeTrApp Conference
por: Corves, Burkhard, et al.
Publicado: (2015)